L
Lianne E. Jacobs
Researcher at University of Texas MD Anderson Cancer Center
Publications - 3
Citations - 49
Lianne E. Jacobs is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Decision aids & Cancer. The author has an hindex of 3, co-authored 3 publications receiving 34 citations.
Papers
More filters
Journal ArticleDOI
From guideline to practice: New shared decision-making tools for colorectal cancer screening from the American Cancer Society.
Robert J. Volk,Viola B. Leal,Lianne E. Jacobs,Andrew M.D. Wolf,Durado Brooks,Richard C. Wender,Robert A. Smith +6 more
TL;DR: The updated guideline emphasizes the importance of communication about CRC screening between health care providers and patients to improve CRC screening utilization and develops decision support tools to engage patients and health care provider in making shared decisions about screening.
Journal ArticleDOI
Randomized trial of a patient-centered decision aid for promoting informed decisions about lung cancer screening: Implementation of a PCORI study protocol and lessons learned.
Lisa M. Lowenstein,Kamisha Hamilton Escoto,Viola B. Leal,Linda Bailey,Therese B. Bevers,Scott B. Cantor,Paul M. Cinciripini,Lianne E. Jacobs,Angelina Esparza,Myrna C.B. Godoy,Ashley J. Housten,Heather Lin,Pamela Luckett,Reginald F. Munden,Vance Rabius,Robert J. Volk +15 more
TL;DR: The methods, stakeholder engagement, and lessons learned from a study comparing a video decision aid to standard educational materials on lung cancer screening decisions, which enrolled and randomized 516 quitline patients, are described.
Journal ArticleDOI
A Review of the Presentation of Overdiagnosis in Cancer Screening Patient Decision Aids
Ashley J. Housten,Lisa M. Lowenstein,Aubri S. Hoffman,Lianne E. Jacobs,Zineb Zirari,Diana S. Hoover,Dawn Stacey,Greg Pratt,Therese B. Bevers,Robert J. Volk +9 more
TL;DR: Over three quarters of cancer screening PDAs addressed concepts related to overdiagnosis/overtreatment, yet terminology was inconsistent and few included probability estimates, which would help guide the design and certification of cancer Screening PDAs.